Records containing: Primary Immune Deficiency Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-15A Pilot Study in the Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients
-
CLINICAL_TRIALS study record update · 2025-11-28Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
-
CLINICAL_TRIALS study record update · 2025-08-08A Pilot Study in the Treatment of Refractory Adenovirus (ADV) Infection With Related Donor ADV Cytotoxic T-Lymphocytes (ADV-CTLs)in Children, Adolescents and Young Adult Recipients
-
CLINICAL_TRIALS study record update · 2025-08-08A Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV) Infections With Related Donor CMV Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients
-
CLINICAL_TRIALS study record update · 2025-08-08A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection With Related Donor EBV Cytotoxic T-Lymphocytes in Children, Adolescents and Young Adult Recipients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-01-28Safety, Tolerability, and Patient Satisfaction of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment by Rapid Push in Patients With Primary or Secondary Immunodeficiency (PID or SID)
-
CLINICAL_TRIALS study record update · 2023-11-07Clinical Phase 3 Study to Monitor the Safety, Tolerability, and Efficacy of Subcutaneous Human Immunoglobulin (CUTAQUIG®) Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases
-
CLINICAL_TRIALS study record update · 2023-02-13Intensive Care Unit and Secondary and Primary Immune Deficiency
-
CLINICAL_TRIALS study record update · 2023-02-01A Multicenter, Non-interventional, Observational, Prospective Study to Assess Hypotension in Patients With Primary Immunodeficiency Disease Treated With Bivigam™ (Human 10%) or Other Commercial Human 10% Immune Globulin (Intravenous) (IGIV) Products During Infusion and up to 72 Hours Post Infusion
-
CLINICAL_TRIALS study record update · 2022-11-14Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study
-
CLINICAL_TRIALS study record update · 2022-07-12Phase I/II Study of CaspaCIDe® T Cells From an HLA-Partially Matched Family Donor After Negative Selection of TCR αβ+T Cells in Pediatric Patients Affected by Hematological Disorders
-
CLINICAL_TRIALS study record update · 2021-09-01Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function
-
CLINICAL_TRIALS study record update · 2021-08-17Clinical Phase III Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability and Safety of Subcutaneous Human Immunoglobulin (Octanorm 16.5%) In Patients With Primary Immunodeficiency Diseases
-
CLINICAL_TRIALS study record update · 2021-02-26Phase II/III Study of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated and Haploidentical Donors After TCR Alfa Beta Negative Selection in Pediatric Patients With Primary Immunodeficiency Diseases
-
CLINICAL_TRIALS study record update · 2020-07-07Phase III Study of Immune Globulin Intravenous (Human) IGIV-SN in Pediatric Subjects With Primary Humoral Immunodeficiency
-
CLINICAL_TRIALS study record update · 2020-03-10Clinical Phase 3 Study to Evaluate the Efficacy, Tolerability and Safety of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases.
-
CLINICAL_TRIALS study record update · 2019-09-04Kuwait National Primary Immunodeficiency Registry (KNPIDR)
-
CLINICAL_TRIALS study record update · 2019-08-07Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data in Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)
-
CLINICAL_TRIALS study record update · 2019-06-10Postmarketing Requirement Non-Interventional 2-armed Study to Evaluate the Safety of Octagam® Immune Globulin Intravenous (Human) 5% Liquid Preparation, With a Special Emphasis on Monitoring, Analysis and Reporting of Thromboembolic Events
-
CLINICAL_TRIALS study record update · 2018-09-06The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease
-
CLINICAL_TRIALS study record update · 2018-02-06Pathophysiologie Angeborener Immundefekte
-
CLINICAL_TRIALS study record update · 2018-01-30Towards Identification of New Inborn Errors of Immunity by Whole Exome/Genome Sequencing
-
CLINICAL_TRIALS study record update · 2017-05-10Immunological Characteristics of Patients With Primary Immunodeficiencies and Inflammatory Bowel Diseases
-
CLINICAL_TRIALS study record update · 2016-10-05An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
-
CLINICAL_TRIALS study record update · 2013-04-09A Multicenter Follow-up Study of Long-term Safety, Tolerability, and Efficacy of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency